The patient described developed 2 separate episodes of insulin resistance and on each occasion daily administration of soluble insulin in a daily dose of 980 units failed to achieve satisfactory control. Both episodes responded to steroid therapy. The maximum binding capacity of the serum for insulin was measured on each occasion; in the first episode it was grossly elevated whereas the second time the level was unremarkable. She is currently free of diabetic complications and satisfactorily controlled on a sulphonylurea and diet.
Introduction
Insulin resistance has been arbitrarily defined as the requirement of more than 200 units of insulin daily for a period greater than 48 hr, in the absence of ketoacidosis, infection or associated endocrinological disorder. It is rare; a large series from the Joslin clinic (Boston, U.S.A.) suggests a frequency of less than one in 1000 diabetic outpatients. The resistant state tends to be self-limiting, the majority of cases remitting within a few months.
A case is now reported where two entirely separate episodes of insulin resistance developed, a situation which, it is claimed, has not been recorded before. The first episode was associated with the presence of a high serum maximum binding capacity (MBC) for insulin but during the second episode the MBC was not significantly raised.
Case report
A 47-year-old West Indian woman was diagnosed as diabetic when she was 36 years old and had been initially controlled with a 150-g carbohydrate diet and tolbutamide 500 mg thrice daily; she was gravida 11, para 10, with 4 perinatal deaths and 4 infants with birth weights > 4.5 kg. Two pregnancies had followed the diagnosis of diabetes. The firstended in a miscarriage (when she was 40 years old) at 2 months' gestation and, during her last pregnancy when she was 41 years old (April 1970) In August 1977 she was re-admitted to hospital and given chlorpropamide. Subsequently her diabetes has been as well controlled on chlorpropamide 500 mg daily and diet, as it had previously been on insulin.
Discussion
It is well recognized that insulin resistance can either follow an insidious increase in insulin requirement, usually over several months or be ushered in more rapidly after an episode of ketoacidosis (Shipp et al., 1965; Malins, 1968) . The present patient demonstrated both presentations on separate occasions, the first phase occurring soon after beginning treatment with insulin and the second some 5 years later. Resistance has been reported in association with many systemic diseases, notably haemochromatosis, liver disease, acanthosis nigricans, blood dyscrasias and reticuloses (Shipp et al., 1965; Malins, 1968) which may only become clinically apparent after an interval of several years from diagnosis of the insulin-resistant state (Shipp et al., 1965; Malins, 1968) . The present patient was thoroughly investigated to find such a cause for her insulin resistance and none has been found. Apart from the rare cases reported in which antibodies to the insulin receptor site have been demonstrated (Kahn et al., 1976) such patients usually have a MBC for insulin of greater than 10 u./l (K. Dixon, personal communication) and this observation can be grossly elevated (Berson and Yallow, 1960) . The MBC is the amount of insulin which will be bound by the serum when it is saturated with insulin. Serum from patients who have never formed antibodies to insulin have a MBC of zero. The first episode in the patient was associated with a very grossly elevated MBC of 114 u./l but in the second episode a modest figure of 3-4 u./l was initially obtained and levels fell progressively during steroid therapy (Fig. 1 
